ITP: a historical perspective

Comparison of intravenous immune globulin and high dose anti-D immune globulin as initial therapy for childhood immune thrombocytopenic purpura

(2010) Ian Kane et al.   BRITISH JOURNAL OF HAEMATOLOGY

Health-related lifestyle in adults and children with primary immune thrombocytopenia (ITP)

(2010) Ameet Sarpatwari et al.   BRITISH JOURNAL OF HAEMATOLOGY

Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom General Practice Research Database

(2010) A. Sarpatwari et al.   HAEMATOLOGICA

Romiplostim or Standard of Care in Patients with Immune Thrombocytopenia

(2010) David J. Kuter et al.   NEW ENGLAND JOURNAL OF MEDICINE

Single nucleotide polymorphism in the methyl-CpG binding domain 4 Gene and the risk for immune thrombocytopenic purpura in Chinese population

(2010) Haifeng Zhao et al.   PLATELETS

International consensus report on the investigation and management of primary immune thrombocytopenia

(2009) D. Provan et al.   BLOOD

Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database

(2009) W. Marieke Schoonen et al.   BRITISH JOURNAL OF HAEMATOLOGY

Pathogenesis of chronic immune thrombocytopenia: increased platelet destruction and/or decreased platelet production

(2009) Diane Nugent et al.   BRITISH JOURNAL OF HAEMATOLOGY

Eltrombopag

(2009) Karly P. Garnock-Jones et al.   DRUGS

Infectious Causes of Chronic Immune Thrombocytopenia

(2009) Roberto Stasi et al.   HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA

Thrombopoietin and Platelet Production in Chronic Immune Thrombocytopenia

(2009) David J. Kuter et al.   HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA

Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial

(2009) James B Bussel et al.   LANCET

Proteomic and Phospho-Proteomic Profile of Human Platelets in Basal, Resting State: Insights into Integrin Signaling

(2009) Amir H. Qureshi et al.   PLoS One

Single nucleotide polymorphism of interleukin-1β associated withHelicobacter pyloriinfection in immune thrombocytopenic purpura

(2009) T. Satoh et al.   TISSUE ANTIGENS

Historical review. The light and shadow of Paul Kaznelson: his life and contribution to hematology

(2008) Yataro Yoshida   ANNALS OF HEMATOLOGY

Of mice and men: an open-label pilot study for treatment of immune thrombocytopenic purpura by an inhibitor of Syk

(2008) A. Podolanczuk et al.   BLOOD

Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab

(2008) R. Stasi et al.   BLOOD

Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP

(2008) J. B. Bussel et al.   BLOOD

Defective circulating CD25 regulatory T cells in patients with chronic immune thrombocytopenic purpura

(2008) J. Yu et al.   BLOOD

Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

(2008) F. Rodeghiero et al.   BLOOD

Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review

(2008) R. Stasi et al.   BLOOD

The effect of anti-CD40 ligand in immune thrombocytopenic purpura

(2008) Vivek L. Patel et al.   BRITISH JOURNAL OF HAEMATOLOGY

Refractory immune thrombocytopenic purpura: current strategies for investigation and management

(2008) Bethan Psaila et al.   BRITISH JOURNAL OF HAEMATOLOGY

Association of Inflammatory Cytokine Gene Polymorphisms with Platelet Recovery in Idiopathic Thrombocytopenic Purpura Patients after the Eradication of Helicobacter pylori

(2008) Takayoshi Suzuki et al.   DIGESTION

Emerging drugs for idiopathic thrombocytopenic purpura in adults

(2008) Xiaofang Li et al.   EXPERT OPINION ON EMERGING DRUGS

Impact of chronic Immune Thrombocytopenic Purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspective

(2008) Susan D Mathias et al.   Health and Quality of Life Outcomes

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial

(2008) David J Kuter et al.   LANCET

Self-reported health-related quality of life in adults with chronic immune thrombocytopenic purpura

(2007) Robert McMillan et al.   AMERICAN JOURNAL OF HEMATOLOGY